<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS157451</article-id><article-id pub-id-type="doi">10.1101/2022.11.21.517352</article-id><article-id pub-id-type="archive">PPR573868</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group><subj-group subj-group-type="europepmc-category"><subject>Covid-19</subject></subj-group></article-categories><title-group><article-title>Comparative aerosol and surface stability of SARS-CoV-2 Variants of Concern</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Bushmaker</surname><given-names>Trenton</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yinda</surname><given-names>Claude Kwe</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Morris</surname><given-names>Dylan H</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Holbrook</surname><given-names>Myndi G</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gamble</surname><given-names>Amandine</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Adney</surname><given-names>Danielle</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">#</xref></contrib><contrib contrib-type="author"><name><surname>Bushmaker</surname><given-names>Cara</given-names></name></contrib><contrib contrib-type="author"><name><surname>van Doremalen</surname><given-names>Neeltje</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fischer</surname><given-names>Robert J</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Plowright</surname><given-names>Raina K</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Lloyd-Smith</surname><given-names>James O</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Munster</surname><given-names>Vincent J</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA</aff><aff id="A2"><label>2</label>Dept. of Microbiology and Cell Biology, Montana State University, Bozeman, MT, USA</aff><aff id="A3"><label>3</label>Dept. of Ecology and Evolutionary Biology, University of California, Los Angeles, Los Angeles, CA, USA</aff><aff id="A4"><label>4</label>Bitterroot Health - Daly Hospital, Hamilton, MT, USA</aff><author-notes><fn id="FN1"><label>#</label><p id="P1">Current affiliation: Lovelace Biomedical Research Institute, Dept. of Comparative Medicine, Albuquerque, NM, USA</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>23</day><month>11</month><year>2022</year></pub-date><pub-date pub-type="preprint"><day>21</day><month>11</month><year>2022</year></pub-date><permissions><ali:free_to_read/><license><license-p>This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.</license-p></license><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">CC0 license</ext-link>.</license-p></license></permissions><abstract><p id="P2">SARS-CoV-2 is transmitted principally via air; contact and fomite transmission may also occur. Variants-of-concern (VOCs) are more transmissible than ancestral SARS-CoV-2. We find that early VOCs show greater aerosol and surface stability than the early WA1 strain, but Delta and Omicron do not. Stability changes do not explain increased transmissibility.</p></abstract></article-meta></front><body><p id="P3">Since the initial emergence of SARS-CoV-2 (Lineage A), new lineages and variants have emerged, typically replacing previously circulating lineages (<xref ref-type="bibr" rid="R1">1</xref>). Five virus variants had been characterized as Variants of Concern (VOCs) by the World Health Organization (<xref ref-type="bibr" rid="R2">2</xref>, <xref ref-type="bibr" rid="R3">3</xref>). To assess whether the transmission advantage of new VOCs may have arisen partly from changes in aerosol and surface stability, we directly compared the Lineage A ancestral virus (WA1 isolate) with VOCs from later timepoints during the pandemic.</p><sec id="S1"><title>The Study</title><p id="P4">We evaluated the stability of SARS-CoV-2 variants in aerosols and on and on high density polyethylene and estimated their decay rates using a Bayesian regression model (see the Methods section in the <xref ref-type="supplementary-material" rid="SD1">Supplementary Appendix</xref>). Aerosols (&lt;5 µm) containing SARS-CoV-2 variants of 10<sup>5.75</sup> - 10<sup>6</sup> TCID<sub>50</sub> (50% tissue-culture infectious dose [TCID<sub>50</sub>] per milliliter [mL]) were generated with a three-jet Collison nebulizer and fed into a Goldberg drum to create an aerosolized environment (<xref ref-type="supplementary-material" rid="SD1">supplemental video</xref>). On polyethylene, 50 µL of a solution containing roughly 10<sup>5</sup> TCID<sub>50</sub> of virus was applied to measure surface stability.</p><p id="P5">For aerosol stability, we directly compared the exponential decay rate of different SARS-CoV-2 isolates (<xref ref-type="table" rid="T1">Table 1</xref>) at time points 0, 3 and 8 hours; the 8-hour time point was chosen to maximize information on decay rate given the observed 3-hour decay. Experiments were performed as single runs (0-to-3 or 0-to-8-hours), with sample collection at the start and end points, to minimize virus loss and humidity changes from repeat sampling. All runs were conducted in triplicate. To estimate quantities of sampled virus, air samples collected at 0, 3 or 8 hours post-aerosolization were analyzed by reverse transcription polymerase chain reaction (qRT-PCR) for the SARS-CoV-2 E-gene to determine the amount of genome copies within the samples. To determine the remaining concentration of viable (infectious) SARS-CoV-2 virions, the samples were titrated on Vero E6 cells. Exponential decay of infectious virus was estimated relative to the amount of genome copies to account for particle settling or other physical loss of viruses.</p><p id="P6">We were able to recover viable SARS-CoV-2 virus from the drum for all VOCs (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The quantity of viable virus decayed exponentially over time (hence a linear decrease in the log<sub>10</sub>TCID<sub>50</sub> per liter of air over time (<xref ref-type="fig" rid="F1">Figure 1B</xref>)). The half-life of the ancestral lineage WA1 in aerosols (posterior median value [2.5% to 97.5% posterior quantiles]) was 3.24 [2.34, 5.09] hours. The B.1, Alpha and Beta viruses appeared to have longer half-lives than WA1: 4.01 [2.77, 7.21] hours for B.1, 6.06 [3.17, 25] hours for Alpha, and 5.03 [3.21, 11.9] hours for Beta. The Delta variant displayed a half-life similar to that of WA1: 3.16 [2.31, 4.89] hours. The Omicron variant displayed a similar or decreased half-life compared to WA1: 2.11 [1.32, 4] hours (<xref ref-type="fig" rid="F1">Figure 1B</xref>). To better quantify the magnitude and certainty of the change, we computed the posterior of the ratio for variant half-life to WA1 half-life for each variant (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Estimated ratios were 1.24 [0.697, 2.42] for B.1, 1.88 [0.846, 7.64] for Alpha, 1.56 [0.842, 3.99] for Beta, 0.981 [0.558, 1.69] for Delta, and 0.652 [0.344, 1.33] for Omicron. That is, initial spike protein divergence from WA1 (heuristically quantified by the number of non-synonymous amino acid substitutions) appeared to produce increased relative stability, but further evolutionary divergence reverted stability back to that of WA1, or even below it (<xref ref-type="fig" rid="F1">Figure 1C</xref>, <xref ref-type="supplementary-material" rid="SD1">Figure S1, Table S1</xref>).</p><p id="P7">Next, we investigated the surface stability of VOCs compared to the ancestral variant on polyethylene. Again, all variants exhibited exponential decay, as indicated by linear decrease in the log<sub>10</sub>TCID<sub>50</sub>/mL over time (<xref ref-type="fig" rid="F2">Figure 2A</xref>). We found a half-life (posterior median [2.5% and 97.5% quantiles]) of 4.83 [4.22, 5.49] hours for WA1, similar to our previous estimates (<xref ref-type="fig" rid="F2">Figure 2B</xref>) (<xref ref-type="bibr" rid="R4">4</xref>). B.1, Alpha, and Beta had slightly longer half-lives: 5.19 [4.49, 5.97] hours for B.1, 5.13 [4.63, 5.71] hours for Alpha, and 5.66 [4.99, 6.56] hours for Beta (<xref ref-type="fig" rid="F2">Figure 2B</xref>). As in aerosols, Delta had a half-life similar to WA1 of 4.36 [3.48, 5.57] hours, and Omicron had a somewhat shorter half-life 3.59 [2.94, 4.41] hours (<xref ref-type="fig" rid="F2">Figure 2B</xref>). To quantify the strength and statistical discernibility of the pattern, we calculated posterior probabilities for the half-life ratio relative to WA1 (<xref ref-type="fig" rid="F2">Figure 2C</xref>). B.1, Alpha, and Beta had half-life ratios to WA1 of 1.08 [0.886, 1.3], 1.06 [0.905, 1.26], and 1.18 [0.978, 1.42], respectively. Delta had a ratio of 0.902 [0.699, 1.19], and Omicron 0.744 [0.582, 0.948].</p></sec><sec id="S2" sec-type="conclusions"><title>Conclusion</title><p id="P8">Several studies have analyzed the stability of SARS-CoV-2 in aerosols in a Goldberg rotating drum.(<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R7">7</xref>) In general, these studies focused on the duration over which infectious virus could be detected. In one study, virus was detected after 16 hours (<xref ref-type="bibr" rid="R6">6</xref>). Studies using the VOCs B.1 and B.1.1.7 did not detect notable differences in aerosol stability compared to ancestral strains (<xref ref-type="bibr" rid="R8">8</xref>).</p><p id="P9">Here, we paired a model-optimized experimental design with Bayesian hierarchical analysis to systematically measure virus half-life across six SARS-CoV-2 variants and directly estimate relative half-lives with full error propagation. We found a small initial increase in aerosol stability from ancestral WA1 to the B.1, Alpha and Beta variants, with some statistical uncertainty. However, we found that Delta has a half-life similar to WA1, and Omicron a shorter one. In surface measurements, the VOCs followed the same pattern of relative stability, confirming that the overall stability of SARS-CoV-2 variants is determined by similar factors in aerosols and on surfaces.(<xref ref-type="bibr" rid="R9">9</xref>)</p><p id="P10">Our study suggests that aerosol stability is likely not a major factor driving the increase in transmissibility observed with several VOCs.(<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R11">11</xref>) The early rise in stability for B.1 and its descendants Alpha and Beta may have been incidentally caused by selection for other viral traits that favored higher transmission. Epidemiological and experimental studies suggest that the window for transmission is typically relatively short (under an hour), and that a modest change in aerosol half-life will not have a discernible impact on the epidemiological level (<xref ref-type="bibr" rid="R12">12</xref>). However, in specific contexts of enclosed spaces, it will remain important to understand the temporal profile of transmission risks after the release of aerosols containing SARS-CoV-2 from an infected individual.</p><p id="P11">Whereas evolutionary selection for prior variants favored high transmission to and from naïve humans(<xref ref-type="bibr" rid="R13">13</xref>), since late 2021 global population-level selection have favored antigenic change, and the consequent ability to transmit to and from non-naïve individuals (<xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R15">15</xref>). But as the example shows, either increased transmissibility in naïves or adaptive antigenic evolution may come at a tolerable cost in environmental stability. Overall, the minor differences in the environmental stability between isolates of different VOCs in aerosols or on surfaces are unlikely to be driving variant population-level epidemiology.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Appendix</label><media xlink:href="EMS157451-supplement-Supplementary_Appendix.pdf" mimetype="application" mime-subtype="pdf" id="d36aAdDbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S3"><title>Acknowledgements</title><p>We would like to thank Michele Adams for clinical specimen acquisition, Friederike Feldmann for experimental support, and Austin Athman for creation of the video. The following SARS-CoV-2 isolates were obtained through: CDC: SARS-CoV-2/human/USA/WA-CDC-WA1/2020, Lineage A. BEI Resources, NIAID, NIH: SARS-CoV-2 variant Alpha (B.1.1.7) (hCoV320 19/England/204820464/2020, EPI_ISL_683466), contributed by Bassam Hallis, and variant Delta (B.1.617.2/) (hCoV-19/USA/KY-CDC-2-4242084/2021, EPI_ISL_1823618). Variant Beta (B.1.351) isolate name: hCoV-19/USA/MD-HP01542/2021, EPI_ISL_890360, was contributed by Johns Hopkins Bloomberg School of Public Health: Andrew Pekosz. Variant Omicron (B.1.1.529. BA.1) isolate name: hCoV-19/USA/GA-EHC-2811C/2021, EPI_ISL_7171744, was contributed Emory University, Emory Vaccine Center: Mehul Suthar. We thank Andrew Pekosz, Mehul Suthar, Emmie de Wit, Brandi Williamson, Sujatha Rashid, Bassam Hallis, Ranjan Mukul, Kimberly Stemple, Bin Zhou, Natalie Thornburg, Sue Tong, Stacey Ricklefs, Sarah Anzick for gracefully sharing viruses or propagating and sequence confirming virus stocks. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) and Defense Advanced Research Projects Agency DARPA PREEMPT # D18AC00031. Contributions of D.H.M., A.G. and J.L.S. were further supported by the National Science Foundation (DEB-1557022) and the UCLA AIDS Institute and Charity Treks. This work was part of NIAID’s SARS-CoV-2 Assessment of Viral Evolution (SAVE) Program.</p><p>Mr. Bushmaker is a biologist in NIAIDs Laboratory of Virology and is interested in high containment pathogens. Dr. Yinda is a postdoctoral research fellow in NIAIDs Laboratory of Virology. He is interested in emerging viruses, and their transmissions potential.</p></ack><fn-group><fn fn-type="con" id="FN2"><p id="P12"><bold>Author contributions</bold></p><p id="P13">Conceptualization: T.B., C.K.Y., A.G., D.M., R.J.F, V.M., and J.L.S.; methodology: T.B., C.K.Y., M.H., and D.R.A., and R.J.F.; resources: C.I.B. and N.v.D.; supervision: V.J.M. and R.K.P.; data curation: T.B., C.K.Y., D.M., R.J.F., and A.G.; writing: T.B., C.K.Y., A.G., D.M., R.K.P., V.M., and J.L-S.; visualization: T.B., C.K.Y., and D.M.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidari</surname><given-names>M</given-names></name><name><surname>Sayfouri</surname><given-names>N</given-names></name><name><surname>Jafari</surname><given-names>H</given-names></name></person-group><article-title>Consecutive Waves of COVID-19 in Iran: Various Dimensions and Probable Causes</article-title><source>Disaster Med Public Health Prep</source><year>2022</year><month>Feb</month><day>14</day><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmcid">PMC9509792</pub-id><pub-id pub-id-type="pmid">35152937</pub-id><pub-id pub-id-type="doi">10.1017/dmp.2022.45</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="web"><collab>World Health Organization</collab><source>Tracking SARS-CoV-2 variants</source><year>2020-2022</year><day>3</day><month>February</month><comment>cited; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/">https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/</ext-link></comment></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konings</surname><given-names>F</given-names></name><name><surname>Perkins</surname><given-names>MD</given-names></name><name><surname>Kuhn</surname><given-names>JH</given-names></name><name><surname>Pallen</surname><given-names>MJ</given-names></name><name><surname>Alm</surname><given-names>EJ</given-names></name><name><surname>Archer</surname><given-names>BN</given-names></name><etal/></person-group><article-title>SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse</article-title><source>Nat Microbiol</source><year>2021</year><month>Jul</month><volume>6</volume><issue>7</issue><fpage>821</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">34108654</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Doremalen</surname><given-names>N</given-names></name><name><surname>Bushmaker</surname><given-names>T</given-names></name><name><surname>Morris</surname><given-names>DH</given-names></name><name><surname>Holbrook</surname><given-names>MG</given-names></name><name><surname>Gamble</surname><given-names>A</given-names></name><name><surname>Williamson</surname><given-names>BN</given-names></name><etal/></person-group><article-title>Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1</article-title><source>N Engl J Med</source><year>2020</year><month>Apr</month><day>16</day><volume>382</volume><issue>16</issue><fpage>1564</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC7121658</pub-id><pub-id pub-id-type="pmid">32182409</pub-id><pub-id pub-id-type="doi">10.1056/NEJMc2004973</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smither</surname><given-names>SJ</given-names></name><name><surname>Eastaugh</surname><given-names>LS</given-names></name><name><surname>Findlay</surname><given-names>JS</given-names></name><name><surname>Lever</surname><given-names>MS</given-names></name></person-group><article-title>Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity</article-title><source>Emerg Microbes Infect</source><year>2020</year><month>Dec</month><volume>9</volume><issue>1</issue><fpage>1415</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC7473326</pub-id><pub-id pub-id-type="pmid">32496967</pub-id><pub-id pub-id-type="doi">10.1080/22221751.2020.1777906</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fears</surname><given-names>AC</given-names></name><name><surname>Klimstra</surname><given-names>WB</given-names></name><name><surname>Duprex</surname><given-names>P</given-names></name><name><surname>Hartman</surname><given-names>A</given-names></name><name><surname>Weaver</surname><given-names>SC</given-names></name><name><surname>Plante</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions</article-title><source>Emerg Infect Dis</source><year>2020</year><month>Sep</month><volume>26</volume><issue>9</issue><pub-id pub-id-type="pmcid">PMC7454081</pub-id><pub-id pub-id-type="pmid">32568661</pub-id><pub-id pub-id-type="doi">10.3201/eid2609.201806</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuit</surname><given-names>M</given-names></name><name><surname>Ratnesar-Shumate</surname><given-names>S</given-names></name><name><surname>Yolitz</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>G</given-names></name><name><surname>Weaver</surname><given-names>W</given-names></name><name><surname>Green</surname><given-names>B</given-names></name><etal/></person-group><article-title>Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight</article-title><source>J Infect Dis</source><year>2020</year><month>Aug</month><day>15</day><volume>222</volume><issue>4</issue><fpage>564</fpage><lpage>71</lpage><pub-id pub-id-type="pmcid">PMC7313838</pub-id><pub-id pub-id-type="pmid">32525979</pub-id><pub-id pub-id-type="doi">10.1093/infdis/jiaa334</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuit</surname><given-names>M</given-names></name><name><surname>Biryukov</surname><given-names>J</given-names></name><name><surname>Beck</surname><given-names>K</given-names></name><name><surname>Yolitz</surname><given-names>J</given-names></name><name><surname>Bohannon</surname><given-names>J</given-names></name><name><surname>Weaver</surname><given-names>W</given-names></name><etal/></person-group><article-title>The stability of an isolate of the SARS-CoV-2 B.1.1.7 lineage in aerosols is similar to three earlier isolates</article-title><source>J Infect Dis</source><year>2021</year><month>Apr</month><day>2</day><pub-id pub-id-type="pmcid">PMC8083468</pub-id><pub-id pub-id-type="pmid">33822064</pub-id><pub-id pub-id-type="doi">10.1093/infdis/jiab171</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>DH</given-names></name><name><surname>Yinda</surname><given-names>KC</given-names></name><name><surname>Gamble</surname><given-names>A</given-names></name><name><surname>Rossine</surname><given-names>FW</given-names></name><name><surname>Huang</surname><given-names>QS</given-names></name><name><surname>Bushmaker</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses</article-title><source>Elife</source><year>2021</year><month>Jul</month><day>13</day><fpage>10</fpage><pub-id pub-id-type="pmcid">PMC8277363</pub-id><pub-id pub-id-type="pmid">33904403</pub-id><pub-id pub-id-type="doi">10.7554/eLife.65902</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Port</surname><given-names>JR</given-names></name><name><surname>Yinda</surname><given-names>CK</given-names></name><name><surname>Avanzato</surname><given-names>VA</given-names></name><name><surname>Schulz</surname><given-names>JE</given-names></name><name><surname>Holbrook</surname><given-names>MG</given-names></name><name><surname>van Doremalen</surname><given-names>N</given-names></name><etal/></person-group><article-title>Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo</article-title><source>Nat Microbiol</source><year>2022</year><month>Feb</month><volume>7</volume><issue>2</issue><fpage>213</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">35017676</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrich</surname><given-names>L</given-names></name><name><surname>Halwe</surname><given-names>NJ</given-names></name><name><surname>Taddeo</surname><given-names>A</given-names></name><name><surname>Ebert</surname><given-names>N</given-names></name><name><surname>Schon</surname><given-names>J</given-names></name><name><surname>Devisme</surname><given-names>C</given-names></name><etal/></person-group><article-title>Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta</article-title><source>Nature</source><year>2022</year><month>Feb</month><volume>602</volume><issue>7896</issue><fpage>307</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC8828469</pub-id><pub-id pub-id-type="pmid">34937050</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-04342-0</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TC</given-names></name><name><surname>Biele</surname><given-names>G</given-names></name><name><surname>Muhlemann</surname><given-names>B</given-names></name><name><surname>Veith</surname><given-names>T</given-names></name><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Beheim-Schwarzbach</surname><given-names>J</given-names></name><etal/></person-group><article-title>Estimating infectiousness throughout SARS-CoV-2 infection course</article-title><source>Science</source><year>2021</year><month>Jul</month><day>9</day><volume>373</volume><issue>6551</issue><pub-id pub-id-type="pmcid">PMC9267347</pub-id><pub-id pub-id-type="pmid">34035154</pub-id><pub-id pub-id-type="doi">10.1126/science.abi5273</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>JY</given-names></name><name><surname>Plante</surname><given-names>KS</given-names></name><name><surname>Plante</surname><given-names>JA</given-names></name><name><surname>Xie</surname><given-names>XP</given-names></name><name><surname>Zhang</surname><given-names>XW</given-names></name><etal/></person-group><article-title>The N501Y spike substitution enhances SARS-CoV-2 infection and transmission</article-title><source>Nature</source><year>2022</year><month>Feb</month><day>10</day><volume>602</volume><issue>7896</issue><fpage>294-+</fpage><pub-id pub-id-type="pmcid">PMC8900207</pub-id><pub-id pub-id-type="pmid">34818667</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-04245-0</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Doremalen</surname><given-names>N</given-names></name><name><surname>Schulz</surname><given-names>JE</given-names></name><name><surname>Adney</surname><given-names>DR</given-names></name><name><surname>Saturday</surname><given-names>TA</given-names></name><name><surname>Fischer</surname><given-names>RJ</given-names></name><name><surname>Yinda</surname><given-names>CK</given-names></name><etal/></person-group><article-title>Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster model</article-title><source>Res Sq</source><year>2022</year><month>Feb</month><day>15</day></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Straten</surname><given-names>KV</given-names></name><name><surname>Guerra</surname><given-names>D</given-names></name><name><surname>Gils</surname><given-names>MJV</given-names></name><name><surname>Bontjer</surname><given-names>I</given-names></name><name><surname>Caniels</surname><given-names>TG</given-names></name><name><surname>Willigen</surname><given-names>HDGV</given-names></name><etal/></person-group><article-title>Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron</article-title><source>Immunity</source><year>2022</year><month>Sep</month><day>13</day><volume>55</volume><issue>9</issue><fpage>1725-+</fpage><pub-id pub-id-type="pmcid">PMC9353602</pub-id><pub-id pub-id-type="pmid">35973428</pub-id><pub-id pub-id-type="doi">10.1016/j.immuni.2022.07.018</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>SARS-CoV-2 variant exponential decay in aerosolized form and corresponding half-lives.</title><p>A: Regression lines showing predicted decay of log10 virus titer over time compared to measured (directly inferred) virus titers. Points show posterior median measured titers; black lines show a 95% credible interval. Point at 3h and 8h are shifted upward by the estimated physical / non-inactivation loss of virus, as estimated from qPCR data (see <xref ref-type="supplementary-material" rid="SD1">Supplementary text Methods</xref>) to enable visual comparison with the predicted exponential decay curve (which reflects inactivation only). Colored lines are random draws from the joint posterior distribution of the exponential decay rate (negative of the slope) and intercept (initial virus titer); this visualizes the range of possible decay patterns for each experimental condition. 10 lines plotted for each drum run (thus 60 per panel). B: Inferred virus half-lives by variant. Violin plots show the shape of the posterior distribution. Dots show the posterior median half-life estimate and black lines show a 68% (thick) and 95% (thin) credible interval. C: Inferred ratio of variant virus half-lives to that of WA1 (fold-change), plotted on a logarithmic scale and centered on 1 (no change). Dot shows the posterior median estimate and black lines show a 68% (thick) and 95% (thin) credible interval.</p></caption><graphic xlink:href="EMS157451-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>SARS-CoV-2 variant exponential decay on an inert surface and corresponding half-lives.</title><p>A: Regression lines showing predicted decay of log10 virus titer over time compared to measured (directly inferred) virus titers. Points show posterior median measured titers; black lines show a 95% credible interval. Colored lines are random draws from the joint posterior distribution of the exponential decay rate (negative of the slope) and intercept (initial virus titer); this visualizes the range of possible decay patterns for each experimental condition. 10 lines plotted per panel for each sampled titer. B: Inferred virus half-lives by variant. Violin plots show the shape of the posterior distribution. Dots show the posterior median half-life estimate and black lines show a 68% (thick) and 95% (thin) credible interval. C: Inferred ratio of variant virus half-lives to that of WA1 (fold-change), plotted on a logarithmic scale and centered on 1 (no change). Dot shows the posterior median estimate and black lines show a 68% (thick) and 95% (thin) credible interval.</p></caption><graphic xlink:href="EMS157451-f002"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>SARS-CoV-2 isolates used in this study with the observed aerosol and surface half-lives.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="top">SARS-CoV-2 isolate</th><th align="center" valign="top">WHO Label</th><th align="center" valign="top">PANGO</th><th align="center" valign="top">GISAID/GenBank</th><th align="center" valign="top">Aerosol half-life (hours)</th><th align="center" valign="top">Surface half-life (hours)</th></tr></thead><tbody><tr><td align="left" valign="top">hu/USA/CA CDC_5574/2020</td><td align="left" valign="top"/><td align="left" valign="top">A</td><td align="left" valign="top">MN985325.1</td><td align="left" valign="top">3.24 [2.34, 5.09]</td><td align="left" valign="top">4.83 [4.22, 5.49]</td></tr><tr><td align="left" valign="top">hCoV-19/USA/MT-RML-7/2020</td><td align="left" valign="top"/><td align="left" valign="top">B.1</td><td align="left" valign="top">MW127503.1</td><td align="left" valign="top">4.01 [2.77, 7.21]</td><td align="left" valign="top">5.19 [4.49, 5.97]</td></tr><tr><td align="left" valign="top">hCoV-19/England/204820464/2020</td><td align="left" valign="top">Alpha</td><td align="left" valign="top">B.1.1.7</td><td align="left" valign="top">EPI_ISL_683466</td><td align="left" valign="top">6.06 [3.17, 25]</td><td align="left" valign="top">5.13 [4.63, 5.71]</td></tr><tr><td align="left" valign="top">hCoV-19/USA/MD-HP01542/2021</td><td align="left" valign="top">Beta</td><td align="left" valign="top">B.1.351</td><td align="left" valign="top">EPI_ISL_890360</td><td align="left" valign="top">5.03 [3.21, 11.9]</td><td align="left" valign="top">5.66 [4.99, 6.56]</td></tr><tr><td align="left" valign="top">hCoV-19/USA/KY-CDC-2-4242084/2021</td><td align="left" valign="top">Delta</td><td align="left" valign="top">B.1.617.2</td><td align="left" valign="top">EPI_ISL_1823618</td><td align="left" valign="top">3.16 [2.31, 4.89]</td><td align="left" valign="top">4.36 [3.48, 5.57]</td></tr><tr><td align="left" valign="top">hCoV-19/USA/WI-WSLH-221686/2021</td><td align="left" valign="top">Omicron</td><td align="left" valign="top">B.1.1.529</td><td align="left" valign="top">EPI_ISL_7263803</td><td align="left" valign="top">2.11 [1.32, 4]</td><td align="left" valign="top">3.59 [2.94, 4.41]</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P14">The half-life of the in aerosols or on surface presented as posterior median value with posterior quantiles</p></fn></table-wrap-foot></table-wrap></floats-group></article>